Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is acquiring a Bioanalyzer 5200 Fragment analyzer system, which includes essential components and installation services. This system is designed for the characterization of nucleic acids and sequencing libraries, offering improved sensitivity and resolution. Interested bidders should refer to the attached RFQ for further details.
This acquisition of Bioanalyzer 5200 Fragment analyzer system for ETB Group at NCATS. The item includes the Bioanalyzer 5200 Fragment analyzer system, computer and monitor, controller and analysis software, capillary array, and installation/familiarization services. The Bioanalyzer 5200 fragement analyzer can characterize nucleic acids and sequencing libraries. The Agilent 5200 is a mid-throughput, electrophoresis machine for the analysis of DNA & RNA. The system utilizes a plate-based, capillary system with a self-loading electrophoretic gel, to analyze as little as 50 pg/uL of RNA or 300 pg/uL of DNA. The 5200 is able to run up to 288 samples without manual intervention from multiwell plates and has improved sensitivity and resolution over the Bioanalyzer 2100.
Please see RFQ attached.
FRAGMENT ANALYZER SYSTEM is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.